Please assess the completion status of the following clinical trial:

Trial Title: Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* chronic obstructive pulmonary disease~* acute respiratory failure under ventilator support for less than 72 hours~* endotracheal tube inserted~Exclusion Criteria:~* confirmed asthma~* Acute Physiology and Chronic Health Evaluation II score over 35~* a co-morbidity of septic shock

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Individualized dosing (Type: EXPERIMENTAL): * Ventilator support~* Determining personal target airway resistance~* Bronchodilator:Salmeterol/fluticasone 4 puffs inhalation every 12 hours until ventilator discontinuation or the 28th day if ventilator-dependent~* Bronchodilator:Ipatropium/salbutamol 1 vial inhalation every 6 hours for the first 3 days~* Steroid:Methylprednisolone 40 mg intravenous injection every 8 hours for the first 3 days~* Additional broncho-dilators inhalation: Salmeterol/fluticasone (Seretide) 4 puffs plus fenoterol (Berotec) 4 puffs inhalation if personal target airway resistance (measured every 8 hours) not met (until ventilator discontinuation or the 28th day if ventilator-dependent)
- Fixed dosing (Type: ACTIVE_COMPARATOR): * Ventilator support~* Determining personal target airway resistance~* Bronchodilator:Salmeterol/fluticasone 4 puffs inhalation every 12 hours until ventilator discontinuation or the 28th day if ventilator-dependent~* Bronchodilator:Ipatropium/salbutamol 1 vial inhalation every 6 hours for the first 3 days~* Steroid:Methylprednisolone 40 mg intravenous injection every 8 hours for the first 3 days~* No additional bronchodilator given if personal target airway resistance (measured every 8 hours) not met

Based on this trial design, predict the completion outcome and termination type (if applicable).